1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Mental Health Analysis & Statistics 2022 - United Kingdom (p4)

Mental Health Analysis & Statistics 2022 - United Kingdom (p4)

91-120 of about 100 reports

Dementia with Diabetes - Market Insights, Epidemiology and Market Forecast–2030

  • $ 6950
  • July 2020
  • 135 pages

‘Dementia with Diabetes—Market Insights, Epidemiology and Market Forecast–2030’ report delivers an in-depth understanding of the Dementia with Diabetes, historical and forecasted epidemiology as ...

  • United States
  • United Kingdom
  • Dementia
  • Diabetes
  • Industry analysis
  • Health Expenditure
  • Dementia Prevalence

Treatment-resistant depression (TRD) - Market Insights, Epidemiology, and Market Forecast - 2030

  • $ 6950
  • June 2020
  • 200 pages

‘Treatment-resistant depression (TRD) - Market Insights, Epidemiology, and Market Forecast - 2030’ report delivers an in-depth understanding of the Treatment-resistant depression (TRD), historical ...

  • United States
  • Japan
  • Therapy
  • Depression
  • Industry analysis
  • Health Expenditure
  • Depression Prevalence

Duchenne Muscular Dystrophy- Market Insight, Epidemiology and Market Forecast -2030

  • $ 6950
  • April 2020
  • 150 pages

‘Duchenne Muscular Dystrophy (DMD) -Market Insights, Epidemiology and Market Forecast– 2030’ report delivers an in-depth understanding of the Duchenne Muscular Dystrophy (DMD), historical and forecasted ...

  • United States
  • Spain
  • Neurological Disorder
  • Industry analysis
  • Health Expenditure

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) – Market Insights, Epidemiology, and Market Forecast—2030

  • $ 6950
  • March 2020
  • 211 pages

‘Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) – Market Insights, Epidemiology, and Market Forecast—2030’ report delivers an in-depth understanding of the Chronic Inflammatory Demyelinating ...

  • Europe
  • United States
  • Neurological Disorder
  • Therapy
  • Industry analysis
  • Health Expenditure

Diabetic Peripheral Neuropathy - Market Insights, Epidemiology, and Market Forecast-2030

  • $ 6950
  • February 2020
  • 167 pages

‘Diabetic Peripheral Neuropathy - Market Insights, Epidemiology, and Market Forecast-2030’ report deliver an in-depth understanding of the disease, historical & forecasted epidemiology as well as the ...

  • Spain
  • Japan
  • Neurological Disorder
  • Industry analysis
  • Smoking Prevalence

UK Protection Insurance 2019: Critical Illness & Income Protection

  • $ 3450
  • July 2019
  • 48 pages

UK Protection Insurance 2019: Critical Illness & Income Protection Summary This report focuses on the major (and closely related) IP and CI product lines.It examines the market size of both IP and ...

  • United Kingdom
  • Pathology
  • Insurance
  • Industry analysis
  • Paid Claims
  • Premiums Written

Neurofibromatosis Type-2 – Market Insights, Epidemiology, and Market Forecast—2030

  • $ 7500
  • January 2021
  • 200 pages

‘Neurofibromatosis Type-2 (NF2)– Market Insights, Epidemiology, and Market Forecast—2030’ report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the ...

  • G8
  • United States
  • Neurological Disorder
  • Therapy
  • Industry analysis
  • Health Expenditure

Gene and Cell Therapies targeting CNS Disorders – Market Insights and Market Forecast – 2026

  • $ 8500
  • April 2021
  • 244 pages

‘Gene and Cell Therapies targeting CNS Disorders – Market Insights and Market Forecast – 2026’ report delivers an in-depth understanding of the market trends of Gene and Cell Therapies targeting ...

  • World
  • Spain
  • Cell Therapy
  • Mental Health
  • Industry analysis
  • Health Expenditure

EU5 Hydrocephalus Shunting Procedures Outlook to 2025

  • $ 3995
  • December 2018
  • 34 pages

EU5 Hydrocephalus Shunting Procedures Outlook to 2025 Summary GlobalData’s new report, EU5 Hydrocephalus Shunting Procedures Outlook to 2025, provides key procedures data on the EU5 Hydrocephalus Shunting ...

  • Spain
  • France
  • Neurological Disorder
  • Industry analysis

Global Neurostimulation Devices Market 2019-2029

  • $ 4724
  • November 2018
  • 166 pages

Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Cortical Stimulators, Epilepsy, Pain Management, Hearing Loss, Incontinence, Gastroparesis, Parkinson’s ...

  • World
  • Europe
  • Ear Disease
  • Analgesic
  • Industry analysis

United Kingdom Hydrocephalus Shunting Procedures Outlook to 2025

  • $ 2995
  • November 2018
  • 15 pages

United Kingdom Hydrocephalus Shunting Procedures Outlook to 2025 Summary GlobalData’s new report, United Kingdom Hydrocephalus Shunting Procedures Outlook to 2025, provides key procedures data on the ...

  • United Kingdom
  • Neurological Disorder
  • Industry analysis

Proteome Sciences Plc (PRM) - Product Pipeline Analysis, 2021 Update

  • $ 750
  • December 2021
  • 45 pages

Summary Proteome Sciences Plc (Proteome Sciences) is a life sciences company that delivers content for personalized medicine through biomarkers, reagents and services.Its proteomics services include drug ...

  • Europe
  • World
  • Dementia
  • Investor presentation
  • Company
  • Direct Sales
  • Medical Devices Sales

EU5 Hydrocephalus Shunts Market Outlook to 2025

  • $ 5995
  • November 2018
  • 121 pages

EU5 Hydrocephalus Shunts Market Outlook to 2025 Summary GlobalData’s new report, EU5 Hydrocephalus Shunts Market Outlook to 2025, provides key market data on the EU5 Hydrocephalus Shunts market. The ...

  • Germany
  • France
  • Neurological Disorder
  • Industry analysis
  • Direct Sales
  • Pump Production

United Kingdom Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and Others

  • $ 5995
  • November 2018
  • 225 pages

United Kingdom Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and Others Summary GlobalData’s new report, United Kingdom ...

  • United Kingdom
  • Neurology
  • Neurological Disorder
  • Annual report
  • Company
  • Direct Sales
  • Pharmaceutical Revenue

Learning Disability, Mental Health & Substance Abuse Facilities in the UK - Industry Market Research Report

  • $ 725
  • November 2021
  • 53 pages

On the mend: Funding has been boosted to help deal with pandemic-induced mental health issues Abstract Learning Disability, Mental Health & Substance Abuse Facilities in the UK Operators in this industry ...

  • United Kingdom
  • Mental Health
  • Neurological Disorder
  • Industry analysis
  • Disposable Income
  • Employment Income

Domiciliary Care in the UK - Industry Market Research Report

  • $ 745
  • December 2020
  • 49 pages

Aiding care: Emergency funding to counteract the effects of COVID-19 is expected to support industry revenue Abstract Domiciliary Care in the UK Companies operating in the Domiciliary Care industry provide ...

  • United Kingdom
  • Northern Europe
  • Health Services
  • Healthcare
  • Industry analysis
  • Employment Income
  • Disposable Income

United Kingdom Hydrocephalus Shunts Market Outlook to 2025

  • $ 4995
  • October 2018
  • 32 pages

United Kingdom Hydrocephalus Shunts Market Outlook to 2025 Summary GlobalData’s new report, United Kingdom Hydrocephalus Shunts Market Outlook to 2025, provides key market data on the United Kingdom ...

  • United Kingdom
  • Neurological Disorder
  • Industry analysis
  • Direct Sales

Multiple Sclerosis (MS) KOL Interview – UK, Southwest

  • $ 599
  • March 2020
  • 14 pages

In this interview, a UK-based key opinion leader (KOL) discusses typical prescribing habits for disease-modifying therapies (DMTs) in MS. This includes first-generation DMTs and the newer, more potent ...

  • United Kingdom
  • Neurological Disorder
  • Industry analysis

Multiple Sclerosis (MS) KOL Interview – UK, London

  • $ 599
  • March 2020
  • 14 pages

In this interview, a UK-based key opinion leader (KOL) discusses typical prescribing habits for disease-modifying therapies (DMTs) in MS. This includes first-generation DMTs and the newer, more potent ...

  • United Kingdom
  • Neurological Disorder
  • Industry analysis

EPIOMIC EPIDEMIOLOGY SERIES: FRIEDREICH’S ATAXIA FORECAST IN 28 MAJOR MARKETS 2018–2028

  • $ 5577
  • September 2018
  • 84 pages

Black Swan Analysis Epiomic™ Epidemiology Forecast Report on Friedreich’s Ataxia in 28 Major Markets Friedreich’s ataxia (FA) is a rare genetic neurodegenerative disorder with the majority of cases ...

  • South Korea
  • Italy
  • Dementia
  • Epidemiology
  • Industry analysis
  • Hospital Discharge
  • Life Expectancy

Neurostimulation Devices Market (2nd Edition), 2018-2030

  • $ 3499
  • September 2018
  • 639 pages

INTRODUCTION The National Academy of Medicine indicates that as many as 100 million people in the US suffer from some form of pain, which has been shown to be associated with a socioeconomic burden of ...

  • United States
  • APAC
  • Chronic Pain
  • Neurological Disorder
  • Industry analysis
  • Drug Approval

Podiatry Services Global Market Strategies and Opportunities to 2021

  • $ 4000
  • July 2018
  • 352 pages

Podiatrists are physicians or surgeons specializing in preventing, diagnosing and treating conditions of lower extremities such as feet and ankle.Podiatrists offer comprehensive care for all situations ...

  • APAC
  • World
  • Musculoskeletal Disorder
  • Cardiovascular Disease
  • Industry analysis
  • Health Provider Density
  • Dates Consumption

EPIOMIC EPIDEMIOLOGY SERIES: FRONTOTEMPORAL LOBE DEMENTIA FORECAST IN 19 MAJOR MARKETS 2018–2028

  • $ 5577
  • July 2018
  • 70 pages

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Frontotemporal Lobe Dementia in 19 Major Markets Frontotemporal lobe dementia (FTD) is a progressive degenerative disorder characterised ...

  • South Korea
  • Japan
  • Dementia
  • Epidemiology
  • Industry analysis
  • Dementia Prevalence
  • Life Expectancy

EPIOMIC EPIDEMIOLOGY SERIES: GAUCHER’S DISEASE FORECAST IN 30 MAJOR MARKETS 2018–2028

  • $ 5577
  • July 2018
  • 120 pages

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Gaucher’s Disease in 30 Major Markets Gaucher’s Disease (GD) is caused by an inherited, autosomal recessive mutation in the GBA ...

  • South Korea
  • India
  • Neurological Disorder
  • Industry analysis
  • Life Expectancy
  • Cancer Incidence

EPIOMIC EPIDEMIOLOGY SERIES: TAY–SACHS DISEASE FORECAST IN 19 MAJOR MARKETS 2018–2028

  • $ 5577
  • July 2018
  • 78 pages

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Tay Sachs Disease (TSD) in 19 Major Markets Hexosaminidase A deficiency (HEX A deficiency) results in a group of neurodegenerative ...

  • Europe
  • Southern Europe
  • Neurological Disorder
  • Industry analysis
  • Life Expectancy

Alzheimer’s Disease KOL Interview – UK

  • $ 599
  • January 2019
  • 14 pages

Overview This interview with a UK key opinion leader (KOL) provides an overview of cost-effectiveness criteria that may be required to bring Alzheimer’s disease products successfully to the clinic in ...

  • United Kingdom
  • Dementia
  • Industry analysis

Corticosteroid 11 Beta Dehydrogenase Isozyme 1 (11 Beta Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family 26C Member 1 or HSD11B1 or EC 1.1.1.146) - Pipeline Review, H1 2018

  • $ 3500
  • April 2018
  • 60 pages

Corticosteroid 11 Beta Dehydrogenase Isozyme 1 (11 Beta Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family 26C Member 1 or HSD11B1 or EC 1.1.1.146) - Pipeline Review, H1 2018 ...

  • World
  • United Kingdom
  • Dementia
  • Hormone
  • Industry analysis
  • Dementia Prevalence
  • Prescription Drug Sales

Major Depressive Disorder KOL Interview – UK

  • $ 599
  • December 2018
  • 11 pages

Overview A UK key opinion leader (KOL) provides insight into the critical unmet needs in the depression market, along with future trends. Key late-phase pipeline drugs for major depressive disorder and ...

  • United Kingdom
  • Depression
  • Industry analysis

EPIOMIC EPIDEMIOLOGY SERIES: AUTISM SPECTRUM DISORDERS FORECAST IN 22 MAJOR MARKETS 2018–2028

  • $ 5577
  • April 2018
  • 88 pages

Black Swan Analysis Epiomic™ Epidemiology Forecast Report on Autism Spectrum Disorders in 22 Major Markets Autism Spectrum Disorders (ASD) or Pervasive Developmental Disorder (PDD) defines a group of ...

  • Europe
  • Northern Europe
  • Mental Health
  • Industry analysis
  • Birth Rate

EPIOMIC EPIDEMIOLOGY SERIES: EPILEPSY FORECAST IN 19 MAJOR MARKETS 2018–2028

  • $ 5577
  • April 2018
  • 86 pages

Black Swan Analysis Epiomic™ Epidemiology Forecast Report on Epilepsy in 19 Major Markets Epilepsy is a complex neurologic disorder characterised by the occurrence of seizures, divided into several types ...

  • South Korea
  • Italy
  • Neurological Disorder
  • Industry analysis
  • Diagnostic Imaging Density

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on